Repair of Ischemic Injury by Pluripotent Stem Cell Based Cell Therapy without Teratoma through Selective

Seung-Ju Cho1, So-Yeon Kim1, Ho-Chang Jeong1

  • 1Department of Life Sciences, College of Natural Sciences, Sogang University, Seoul 121-742, Korea.

Stem Cell Reports
|November 21, 2015
PubMed

Insights

Pluripotent stem cells (PSCs) expressing the KillerRed (KR) suicide gene can be selectively eliminated by light, preventing teratoma formation. This genetic approach offers a safer alternative to chemical methods for future stem cell therapies.

Area of Science:

  • Regenerative Medicine
  • Molecular Biology
  • Biotechnology

Background:

  • Pluripotent stem cells (PSCs) hold great therapeutic potential but pose a risk of teratoma formation.
  • Current chemical methods to eliminate undifferentiated PSCs may cause off-target toxicities.
  • Novel strategies are needed to ensure the safety of PSC-based therapies.

Purpose of the Study:

  • To develop a light-inducible suicide gene system for selective PSC ablation.
  • To evaluate the efficacy of this system in preventing teratoma formation.
  • To assess the functional integrity of differentiated cells derived from modified PSCs.

Main Methods:

  • Genetically engineered PSCs to express the KillerRed (KR) phototoxicity gene.
  • Induced selective cell death of KR-expressing PSCs using visible light.
  • Assessed teratoma formation inhibition in vivo.
  • Evaluated the functionality of differentiated endothelial cells in vitro and in vivo.

Main Results:

  • Visible light exposure efficiently eliminated KR-expressing PSCs (KR-PSCs).
  • Teratoma formation was successfully inhibited using this phototoxic approach.
  • Endothelial cells derived from KR-modified PSCs remained functional and capable of repairing ischemic injury.
  • Light exposure did not compromise the function of differentiated endothelial cells.

Conclusions:

  • The KR suicide gene system provides a highly selective method for ablating undifferentiated PSCs.
  • This phototoxic genetic strategy effectively prevents teratoma formation.
  • Controlled KR expression in PSCs is a viable and safe approach for future stem cell therapies, preserving the function of differentiated progeny.

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.2K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.6K
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.5K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K